Health & Environmental Research Online (HERO)


Print Feedback Export to File
3856479 
Journal Article 
Observation of emerging per- and polyfluoroalkyl substances (PFASs) in Greenland marine mammals 
Gebbink, WA; Bossi, R; Rigét, FF; Rosing-Asvid, A; Sonne, C; Dietz, R 
2016 
Yes 
Chemosphere
ISSN: 0045-6535
EISSN: 1879-1298 
Elsevier 
OXFORD 
144 
Elsevier 
2384-2391 
English 
is supplemented by 10492342 : Supplemental material
The present pilot study examined emerging per- and polyfluoroalkyl substances (PFASs), i.e., a suite of short chain perfluoroalkyl acids (PFAAs), PFAA precursors and replacement chemicals, and legacy PFASs (long chain length PFAAs) in livers from ringed seals, polar bears and, for the first time, killer whales from East Greenland collected in 2012-2013. Among the emerging PFASs, perfluorobutanesulfonic acid (PFBS) and F-53B (a chlorinated polyfluorinated ether sulfonic acid) were detected in Arctic wildlife, albeit at concentrations approximately four orders of magnitude lower compared to perfluorooctanesulfonic acid (PFOS). PFOS was positively correlated with F-53B, but not PFBS in all three species. A total of 17 PFASs were detected in killer whales, including in a mother-fetus pair, demonstrating maternal transfer. ∑PFAS concentrations in killer whales (269 ± 90 ng/g) were comparable to concentrations found in ringed seals (138 ± 7 ng/g), however, an order of magnitude lower compared to concentrations found in polar bear livers (2336 ± 263 ng/g). Patterns of long chain PFAAs in killer whales differed from the pattern in ringed seals and polar bears. Of the monitored PFAA precursors, only perfluorooctanesulfonamide (FOSA) was detected in all three species, and FOSA/PFOS ratios and isomer patterns indicated that killer whales have a potential lower metabolic capacity to degrade FOSA compared to polar bears and ringed seals. 
Per- and polyfluoroalkyl substances; Replacement chemicals; F-53B; PFBS; PFOS and FOSA isomers; Marine mammals; East Greenland 
PFAS
• Additional PFAS (formerly XAgency)
• Expanded PFAS SEM (formerly PFAS 430)
     Litsearch: September 2019
          Web of Science
     Not prioritized for screening
     Perfluorooctane
• ^Per- and Polyfluoroalkyl Substances (PFAS)
     PFOA (335-67-1) and PFOS (1763-23-1)
          Literature Search – Adverse outcome pathway (2015-present)
               Pubmed
               WOS
     PFBS (375-73-5)
          Literature Search
               Pubmed
               WOS
     PFOSA (754-91-6)
          Literature Search
               Pubmed
               WOS
• PFAS 150
     Literature Search Update December 2020
          PubMed
          WOS
     Literature Search August 2019
          PubMed
          Web of Science
          ToxNet
     Screened Studies
          Supplemental
     Perfluorinated compounds
     Perfluorobutanesulfonic acid
     Perfluorobutanesulfonyl fluoride
     Perfluorooctane
     Perfluorooctanesulfonamide
     Perfluorooctanesulfonic acid
• PFBA
     Protocol References
• PFBS
          Pubmed
          WOS
          Excluded/Not on Topic
     Search
          PubMed
          WOS
     Excluded
          WOS
     Scopus: April 2021
• PFOA (335-67-1) and PFOS (1763-23-1)
     Literature Search – Adverse outcome pathway (2015-present)
          Pubmed
          WOS
     Screening Results
          Excluded/Not on Topic
     Literature Search Update (2013-2019)
          PubMed
          WOS
• PFOSA
     Literature Search
          Pubmed
          WOS
     Screening Results
          Excluded/Not on Topic
• Yale PFAS Liver study